Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension.

IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL
Özlem Güngör Tunçer, Mecbure Nalbantoglu, Elvan Alper Sengul, Betül Baykan
{"title":"Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension.","authors":"Özlem Güngör Tunçer,&nbsp;Mecbure Nalbantoglu,&nbsp;Elvan Alper Sengul,&nbsp;Betül Baykan","doi":"10.14744/agri.2021.05025","DOIUrl":null,"url":null,"abstract":"<p><p>We herein present a 40-year-old female physician who was diagnosed with idiopathic intracranial hypertension (IIH) 4 years ago. In the last years, the patient was in remission without any medications. Since the onset of COVID-19 pandemic, she has been stressfully working in the high-risk area, therefore using personal protective equipment (N95 mask, protective clothing, goggles, and protective cap) during the day for extended periods. Her headaches recurred and the patient was diagnosed with a relapse of IIH; acetazolamide and afterward topiramate were initiated, with diet treatment. Symptomatic metabolic acidosis, which is otherwise a rare side effect of the IIH treatment and not seen in her first attack even with higher doses, developed during the follow-up, presenting with shortness of breath and chest tightening. The emerging problems of IIH diagnosis and management during the COVID-19 pandemic will be discussed.</p>","PeriodicalId":45603,"journal":{"name":"Agri-The Journal of the Turkish Society of Algology","volume":"35 2","pages":"107-110"},"PeriodicalIF":0.8000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Agri-The Journal of the Turkish Society of Algology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/agri.2021.05025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

We herein present a 40-year-old female physician who was diagnosed with idiopathic intracranial hypertension (IIH) 4 years ago. In the last years, the patient was in remission without any medications. Since the onset of COVID-19 pandemic, she has been stressfully working in the high-risk area, therefore using personal protective equipment (N95 mask, protective clothing, goggles, and protective cap) during the day for extended periods. Her headaches recurred and the patient was diagnosed with a relapse of IIH; acetazolamide and afterward topiramate were initiated, with diet treatment. Symptomatic metabolic acidosis, which is otherwise a rare side effect of the IIH treatment and not seen in her first attack even with higher doses, developed during the follow-up, presenting with shortness of breath and chest tightening. The emerging problems of IIH diagnosis and management during the COVID-19 pandemic will be discussed.

特发性颅内高压复发期间代谢性酸中毒的治疗。
我们在此报告一位40岁的女医师,她在4年前被诊断为特发性颅内高压(IIH)。在过去的几年里,病人没有服用任何药物,病情得到了缓解。自2019冠状病毒病大流行以来,她一直在高风险地区工作,压力很大,因此白天长时间佩戴个人防护装备(N95口罩、防护服、护目镜、防护帽)。头痛复发,诊断为IIH复发;开始使用乙酰唑胺和托吡酯,并辅以饮食治疗。症状性代谢性酸中毒,这是IIH治疗的罕见副作用,即使在更高剂量的治疗中也未在她的第一次发作中出现,在随访期间出现呼吸短促和胸闷。讨论2019冠状病毒病大流行期间IIH诊断和管理的新问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.00
自引率
16.70%
发文量
22
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信